HALISTER: Reckitt Benckiser to Buy Mead Johnson for $90/Share in Cash

Reckitt Benckiser to Buy Mead Johnson for $90/Share in Cash

(Bloomberg) -- Reckitt Benckiser to acquire Mead Johnson Nutrition for $90/share in cash, valuing Mead Johnson’s equity at $16.6b.
  • Total value of transaction $17.9b including Mead Johnson’s net debt
  • Estimated GBP200m in annual cost savings by end of third full year
  • Expected to be accretive to adjusted diluted EPS in first full year and double-digit accretive by third year
  • Committed debt financing in place, Reckitt expects to retain a strong investment grade credit rating
  • Subject to shareholder and regulatory approvals, expected completion by end of 3Q 2017
  • Statement
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
MJN US (Mead Johnson Nutrition Co)
RB/ LN (Reckitt Benckiser Group PLC)

To de-activate this alert, click here

UUID: 7947283